Cargando…

Dysbiosis in the Human Microbiome of Cholangiocarcinoma

Cholangiocarcinoma (CCA) is the most common malignant tumor of the biliary system with a very poor prognosis. The human microbiome, which is the sum of the genetic information of human microorganisms, plays an important role in regulating the digestion, absorption, immune response, and metabolism of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao, Benchen, Ren, Tong, Wang, Xuemei, Wang, Haiyu, Zou, Yawen, Sun, Ying, Liu, Shanshuo, Ren, Zhigang, Yu, Zujiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633309/ https://www.ncbi.nlm.nih.gov/pubmed/34867436 http://dx.doi.org/10.3389/fphys.2021.715536

Ejemplares similares

Nanosecond pulse effectively ablated hepatocellular carcinoma with alterations in the gut microbiome and serum metabolites
por: Zou, Yawen, et al.
Publicado: (2023)

Gut Microbiome Distinguishes Patients With Epilepsy From Healthy Individuals
por: Cui, Guangying, et al.
Publicado: (2022)

Serum metabolome alterations in patients with early nonalcoholic fatty liver disease
por: Wang, Xuemei, et al.
Publicado: (2022)

Characterization of the Human Oropharyngeal Microbiomes in SARS‐CoV‐2 Infection and Recovery Patients
por: Gao, Ming, et al.
Publicado: (2021)

Alterations of the oral and gut mycobiome and cytokines during long-term follow-up of COVID-19 convalescents
por: Ren, Zhigang, et al.
Publicado: (2023)

The role of tumor microenvironment reprogramming in primary liver cancer chemotherapy resistance
por: Zhao, Chunyu, et al.
Publicado: (2022)

Oral Microbiome Characteristics in Patients With Autoimmune Hepatitis
por: Rao, Benchen, et al.
Publicado: (2021)

RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

Immune response induced by novel coronavirus infection
por: Sun, Ying, et al.
Publicado: (2022)

The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
por: Wang, Haiyu, et al.
Publicado: (2020)

Alterations in the human oral and gut microbiomes and lipidomics in COVID-19
por: Ren, Zhigang, et al.
Publicado: (2021)

Alterations in the human oral microbiome in cholangiocarcinoma
por: Rao, Ben-Chen, et al.
Publicado: (2022)

Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals
por: Lou, Jiamin, et al.
Publicado: (2020)

The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment
por: Gao, Feng, et al.
Publicado: (2022)

Oral Fungal Alterations in Patients with COVID‐19 and Recovered Patients
por: Hu, Xiaobo, et al.
Publicado: (2023)

A novel predicted model for hypertension based on a large cross-sectional study
por: Ren, Zhigang, et al.
Publicado: (2020)

SPATS2, negatively regulated by miR-145-5p, promotes hepatocellular carcinoma progression through regulating cell cycle
por: Dong, Gang, et al.
Publicado: (2020)

Potential Associations Between Microbiome and COVID-19
por: Wang, Huifen, et al.
Publicado: (2021)

Dysbiosis: The first hit for digestive system cancer
por: Mei, Si, et al.
Publicado: (2022)

Microbiome dysbiosis occurred in hypertrophic scars is dominated by S. aureus colonization
por: Yu, Jiarong, et al.
Publicado: (2023)

Associations between dysbiosis gut microbiota and changes of neurotransmitters and short-chain fatty acids in valproic acid model rats
por: Zhong, Jiu-Gen, et al.
Publicado: (2023)

Dysbiosis of saliva microbiome in patients with oral lichen planus
por: Yu, Fei Yan, et al.
Publicado: (2020)

Alterations of the Human Gut Microbiome in Chronic Kidney Disease
por: Ren, Zhigang, et al.
Publicado: (2020)

Epigenetics, 1-Carbon Metabolism, and Homocysteine During Dysbiosis
por: Singh, Mahavir, et al.
Publicado: (2021)

Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma
por: Saab, Massa, et al.
Publicado: (2021)

Dysbiosis of the Gut Microbiome in Lung Cancer
por: Zhuang, He, et al.
Publicado: (2019)

Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma
por: Pomyen, Yotsawat, et al.
Publicado: (2023)

Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease
por: Sultan, Salma, et al.
Publicado: (2021)

Vaginal biogenic amines: biomarkers of bacterial vaginosis or precursors to vaginal dysbiosis?
por: Nelson, Tiffanie M., et al.
Publicado: (2015)

Microbiome Structure and Mucosal Morphology of Jejunum Appendix and Colon of Rats in Health and Dysbiosis
por: Shao, Chenyi, et al.
Publicado: (2023)

Dysbiosis, Host Metabolism, and Non-communicable Diseases: Trialogue in the Inborn Errors of Metabolism
por: Montanari, Chiara, et al.
Publicado: (2021)

Dysbiosis of the microbiome in gastric carcinogenesis
por: Castaño-Rodríguez, Natalia, et al.
Publicado: (2017)

Exploration of Crucial Mediators for Carotid Atherosclerosis Pathogenesis Through Integration of Microbiome, Metabolome, and Transcriptome
por: Ji, Lei, et al.
Publicado: (2021)

Potential Roles of the Free Salivary Microbiome Dysbiosis in Periodontal Diseases
por: Diao, Jing, et al.
Publicado: (2021)

Dysbiosis of human gut microbiome in young-onset colorectal cancer
por: Yang, Yongzhi, et al.
Publicado: (2021)

Metabolome of human gut microbiome is predictive of host dysbiosis
por: Larsen, Peter E., et al.
Publicado: (2015)

Systematic Microbiome Dysbiosis Is Associated with IgA Nephropathy
por: Cai, Fengtao, et al.
Publicado: (2023)

Mucosal microbiome dysbiosis in gastric carcinogenesis
por: Coker, Olabisi Oluwabukola, et al.
Publicado: (2018)

The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes
por: Zheng, Yanping, et al.
Publicado: (2021)

Intestinal Epithelial Cells Respond to Chronic Inflammation and Dysbiosis by Synthesizing H(2)O(2)
por: Burgueño, Juan F., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vb4qcokdil9ajub5r0ao94fa14